TOI

TOI Cost of Revenue

$496.70MTTM · USD

Period ending:

TOI FY Cost of RevenueUSD
TOI FY Cost of Revenue2018-12-31: $86.88M2019-12-31: $125.46M2020-12-31: $150.64M2021-12-31: $162.16M2022-12-31: $200.39M2023-12-31: $264.67M2024-12-31: $339.42M2025-12-31: $426.29M$426.29M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TOI cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Oncology Institute Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
426,294,000
339,415,000
264,666,000
200,390,000
162,155,000
150,635,685
125,464,564
86,878,527

Compare cost of revenue

All TOI financial metrics · TOI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.